<DOC>
	<DOCNO>NCT02476084</DOCNO>
	<brief_summary>The purpose study determine kinetics change quantitative measure joint inflammation state art power Doppler vascular image identify biomarkers biological sample ( synovial biopsy , DNA , RNA , PBMC , serum , plasma , urine stool sample ) parallel cohort RA patient undergo different treatment . This achieve implement MSUS assessment , standard laboratory technique ( ELISAs , gene profiling , transcriptome analysis etc . ) novel CyTOF™ technology .</brief_summary>
	<brief_title>Biomarker Signature Musculoskeletal Ultrasound Profile Rheumatoid Arthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Written confirm diagnosis Rheumatoid Arthritis per ACR/EULAR 2010 criterion . If patient oral corticosteroid , dose must stable 6 week prior baseline visit . Willingness ability comply study procedure . Any systemic inflammation condition ( RA ) , connective tissue disease chronic pain disorder may interfere interpretation outcome data . Examples include psoriatic arthritis , reactive arthritis , gout , systemic lupus erythematosus ( SLE ) , polymyalgia rheumatic and/or temporal arteritis , Lyme 's disease , fibromyalgia chronic fatigue syndrome . Major surgery plan within 8 week prior screen plan surgery throughout study period . Treatment investigational agent ≤ 4 week prior baseline ( 5 ≤ halflives investigational drug , whichever long ) . Intramuscular/intraarticular glucocorticoid 6 week prior baseline visit . Active infection . Septic arthritis within native joint within last 12 month . Sepsis prosthetic joint within 12 month indefinitely joint remains situ . Known HIV hepatitis B/C infection . Latent TB infection unless complete adequate antibiotic prophylaxis . Malignancy ( basal cell carcinoma ) within last 10 year . New York Heart Association ( NYHA ) grade 3 4 congestive cardiac failure . Demyelinating disease . Presence transplant organ ( exception corneal transplant &gt; 3 month prior screen ) . Known recent substance abuse ( drug alcohol ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>